SE7909105L - Farmaceutiska kompositioner pa basis av aryltrifluoretanol - Google Patents

Farmaceutiska kompositioner pa basis av aryltrifluoretanol

Info

Publication number
SE7909105L
SE7909105L SE7909105A SE7909105A SE7909105L SE 7909105 L SE7909105 L SE 7909105L SE 7909105 A SE7909105 A SE 7909105A SE 7909105 A SE7909105 A SE 7909105A SE 7909105 L SE7909105 L SE 7909105L
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
aryltrifluorethanol
compositions based
aryltrifluoroethanol
hyperpyretic
Prior art date
Application number
SE7909105A
Other languages
English (en)
Swedish (sv)
Inventor
M Vincent
G Remond
J Bure
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of SE7909105L publication Critical patent/SE7909105L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
SE7909105A 1978-11-03 1979-11-02 Farmaceutiska kompositioner pa basis av aryltrifluoretanol SE7909105L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7831096A FR2440353A1 (fr) 1978-11-03 1978-11-03 Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament

Publications (1)

Publication Number Publication Date
SE7909105L true SE7909105L (sv) 1980-05-04

Family

ID=9214422

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7909105A SE7909105L (sv) 1978-11-03 1979-11-02 Farmaceutiska kompositioner pa basis av aryltrifluoretanol
SE7909106A SE7909106L (sv) 1978-11-03 1979-11-02 Nya aryltrifluoretanoler, sett att framstella dessa samt deras anvendning som terapeutika

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7909106A SE7909106L (sv) 1978-11-03 1979-11-02 Nya aryltrifluoretanoler, sett att framstella dessa samt deras anvendning som terapeutika

Country Status (27)

Country Link
US (2) US4285943A (fr)
JP (2) JPS5566548A (fr)
AR (2) AR223989A1 (fr)
AT (1) AT368483B (fr)
AU (1) AU527630B2 (fr)
BE (2) BE879786A (fr)
CA (2) CA1142087A (fr)
CH (2) CH641043A5 (fr)
DD (2) DD147048A5 (fr)
DE (2) DE2944294A1 (fr)
DK (2) DK461679A (fr)
EG (1) EG14114A (fr)
ES (1) ES8101538A1 (fr)
FI (2) FI793444A7 (fr)
FR (1) FR2440353A1 (fr)
GB (2) GB2038802B (fr)
GR (2) GR68015B (fr)
IL (2) IL58621A0 (fr)
IT (2) IT7950715A0 (fr)
MA (2) MA18629A1 (fr)
NL (2) NL7908099A (fr)
NZ (2) NZ192021A (fr)
OA (2) OA06373A (fr)
PT (2) PT70407A (fr)
SE (2) SE7909105L (fr)
SU (1) SU925247A3 (fr)
ZA (2) ZA795870B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
WO2010091894A2 (fr) 2009-02-16 2010-08-19 Giuliani International Limited Méthodes de traitement de troubles liés aux cheveux
CN109999017A (zh) 2012-02-09 2019-07-12 诺格拉制药有限公司 治疗纤维化的方法
CN104284655B (zh) 2012-04-18 2017-10-27 诺格拉制药有限公司 治疗乳糖不耐受的方法
EP4495101A3 (fr) 2019-02-08 2025-04-30 Nogra Pharma Limited Procédé de fabrication d'acide 3-(4'-aminophényl)-2-méthoxypropionique, et analogues et intermédiaires de celui-ci

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142683A (en) * 1961-08-14 1964-07-28 Parke Davis & Co 1-pyridyl-1, 2-diaryl-3-trifluoro-propan-2-ols and a process for their preparation
US3531487A (en) * 1966-10-25 1970-09-29 Hoffmann La Roche 4-(n,n-disubstituted-amino)-piperidines
DE1618007A1 (de) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-monohalogenphenylaethanolaminen
US3821231A (en) * 1971-10-15 1974-06-28 E Lavrinovich Method for preparation of n-substituted 4-aniline piperidines
GB1411783A (en) * 1972-02-24 1975-10-29 Wyeth John & Brother Ltd Piperidine derivatives
FR2340734A1 (fr) * 1976-02-13 1977-09-09 Roussel Uclaf Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
DE2659117A1 (de) * 1976-12-28 1978-07-06 Consortium Elektrochem Ind Trichlormethyl-(3-pyridyl)-carbinol
DK444278A (da) * 1977-10-07 1979-04-08 Science Union & Cie Arylalkylalkansyrer og fremgangsmaade til fremstilling heraf

Also Published As

Publication number Publication date
GB2038802A (en) 1980-07-30
IL58620A (en) 1982-12-31
OA06373A (fr) 1981-08-31
CH641043A5 (fr) 1984-02-15
NL7908099A (nl) 1980-05-07
DD151445A5 (de) 1981-10-21
NZ192021A (en) 1982-09-07
PT70407A (en) 1979-12-01
CA1142087A (fr) 1983-03-01
GB2034587B (en) 1983-02-09
FI793445A7 (fi) 1981-01-01
CA1139763A (fr) 1983-01-18
US4404215A (en) 1983-09-13
AU5241679A (en) 1980-05-08
DE2944293A1 (de) 1980-05-08
DD147048A5 (de) 1981-03-18
ES485656A0 (es) 1980-12-16
AR223989A1 (es) 1981-10-15
SU925247A3 (ru) 1982-04-30
SE7909106L (sv) 1980-05-04
NL7908101A (nl) 1980-05-07
GR68015B (fr) 1981-10-27
JPS5566548A (en) 1980-05-20
GR69726B (fr) 1982-07-09
JPS5566510A (en) 1980-05-20
ES8101538A1 (es) 1980-12-16
ZA795871B (en) 1980-10-29
DK461679A (da) 1980-05-04
FI793444A7 (fi) 1981-01-01
BE879787A (fr) 1980-04-30
NZ192020A (en) 1982-12-21
ATA701679A (de) 1982-02-15
IL58620A0 (en) 1980-02-29
FR2440353A1 (fr) 1980-05-30
CH647225A5 (fr) 1985-01-15
GB2038802B (en) 1982-12-08
AU527630B2 (en) 1983-03-17
OA06372A (fr) 1981-08-31
IT7950715A0 (it) 1979-10-31
IT7950714A0 (it) 1979-10-31
PT70408A (fr) 1979-12-01
ZA795870B (en) 1980-10-29
AR223990A1 (es) 1981-10-15
DE2944294A1 (de) 1980-05-08
EG14114A (en) 1983-03-31
BE879786A (fr) 1980-04-30
MA18628A1 (fr) 1980-07-01
US4285943A (en) 1981-08-25
IL58621A0 (en) 1980-02-29
AT368483B (de) 1982-10-11
DK461579A (da) 1980-05-04
GB2034587A (en) 1980-06-11
MA18629A1 (fr) 1980-07-01

Similar Documents

Publication Publication Date Title
NL7602704A (nl) Werkwijze en inrichting voor de behandeling van waterhoudende stoffen, alsmede toepassing van de werkwijze op de vervaardiging van gepasteuriseerd droogslib.
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO158741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere.
OA05577A (fr) Procédé de préparation de compositions pharmaceutiques renfermant des pyréthrinoïdes.
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NL189127C (nl) Werkwijze voor de bereiding van 1,1-diesters.
NL7613900A (nl) Werkwijze voor de bereiding van sterolglycosiden uit planten.
NL7901038A (nl) Fixeermiddel voor parfumcomposities.
NL183527C (nl) Werkwijze voor de bereiding van bitumen-polymeersamenstellingen.
NO794063L (no) Fremgangsmaate til behandling av utskillingsherdbare ikke-jern-materialer.
SE7909105L (sv) Farmaceutiska kompositioner pa basis av aryltrifluoretanol
PT66089B (en) Process for preparing 1,2-benzisothiazolin-3-ona with anti-thrombotic effect application of same for the preparationof pharmaceutical compositions with anti-thrombic effect and application of these pharmaceutical compositions for the treatment of thrombosis
NL7512745A (nl) Werkwijze voor de bereiding van steriliserende samenstellingen en de toepassing ervan.
NL7806658A (nl) Werkwijze voor de bereiding van 7,8-dihydro- 14-hydro- xynormorfine.
NL188044C (nl) Werkwijze voor de bereiding van bitumen-polymeer samenstellingen, alsmede de hieruit gevormde voortbrengselen.
SE7506293L (sv) Farmaceutiska kompositioner for behandling av hyperkolesterolemi.
NL7613810A (nl) Werkwijze voor de bereiding van herbicidemeng- sels, werkwijze voor de bereiding van werkzame 1,4-difenyl-3-pyrazolin-5-onen en verbindingen, verkregen volgens deze werkwijze.
NL187577C (nl) 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
NL7600939A (nl) Werkwijze voor de bereiding van 2,5-dichloor- -p-xyleen.
NL7808881A (nl) Werkwijze voor de bereiding van 1,1,1,2-tetrafluore- thaan.
NL7901139A (nl) Werkwijze voor de vervaardiging van uit galliumarsenide bestaande inrichtingen.
FI791424A7 (fi) Substituoidut 8-hydroksi-1-fenyyli-2,3,4,5-tetrahydro-1H-3- bentsatsepiinit, menetelmä niiden valmistamiseksi jniitä sisältävät farmaseuttiset seokset.
NL7804406A (nl) Werkwijze voor de bereiding van 1.2-dichloorethaan.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7909105-4